#Biktarvy

[spidersgeorgsblog]

I hate to be an online beggar but my clinic is now charging for my HIV meds that used to be free. Biktarvy is around $3000 but I still have to pay $150 which I don’t have and if anyone out there can help I would greatly appreciate it. I can provide proof of my diagnosis.

Cashapp: $md0669

PayPal: javicruz1992@gmail.com

Any amount can help since I’m only 8 pills away from needing another refill. This medication keeps me undetectable and safe. If anyone can help pls do.

[sunflowers666]

trial sponsored by gilead.. "Lenacapavir is not a new drug. It’s been approved by the FDA in the United States for multi-drug resistant HIV treatment since 2022. But PURPOSE 1 is the first clinical trial to test it for HIV prevention." ... "Lenacapavir’s cost as HIV treatment in the United States in 2023 was $42,250 per new patient per year."

itd be cool if someone figured out how to steal it! its neat that its so long lasting nd injectable. id heard abt cabotegravir/rilpivirine which gets injected once monthly for HIV treatment, but i dont kno much else about it. apparently lenacapavir is a new mechanism than a lot of the other ones ive read abt which is interesting

This is a cool result: current oral PrEP requires a daily pill, but a trial of a twice-yearly injection of lenacapavir has proven so effective that the trial being conducted was ended early to give all participants the drug. Not only do twice-yearly injections avoid the problem of having to remember to take a pill every day, they also may have less stigma, which has been a problem for PrEP in the past.

[xtruss]

An UWS CVS. Photo By Ed Hersh

UWS Independent Pharmacies Face Existential Threat From PBMs: Survey

— September 25, 2024 | By Ed Hersh | Westside Rag | New York, NY

Small Independent Pharmacies on the Upper West Side — and Citywide– say they face continued existential threats from what they claim is a Conflict-of-Interest-Ridden insurance reimbursement system that favors the big chain pharmacies.

In a recent survey of 176 independent pharmacies, released by the New York City Pharmacists Society, 92 percent of independent pharmacists say they were forced to turn away patients in the previous six months because insurance reimbursements they receive for many Brand-Name Drugs are actually below the cost they must pay for them. These include Eliquis, Entresto, Humira, Jardiance, Ozempic, Xarelto, Biktarvy, and Many Other Medications, often critical for managing chronic conditions and improving quality of life.

“The untold story is that there are so many people trying to find an independent pharmacy to fill a prescription, but they can’t because the pharmacies can’t afford to fill that prescription,” an Upper West Side independent pharmacist told us, anonymously for fear of being shut out of the reimbursement system. “Even though pharmacies must, by contract, fill all prescriptions they are sent, some independent pharmacies have found a way around it. There’s nothing to force them to order the medication,” he admitted. “Probably by now, you know which drugs you’re going to have to sell at a big loss. So, you probably don’t keep those around for that reason.”

What’s behind it? Independent pharmacies blame Pharmacy Benefit Managers (PBMs). As we first reported over a year ago, PBMs are the controversial middlemen between insurers, patients, drug makers, and pharmacies. You may not have heard of PBMs, but if you have insurance, you have dealt with them. On behalf of insurance companies, they negotiate prices with drug companies and set the prices that pharmacies are paid by the insurers, and then what the pharmacies can charge their customers. This includes those with Private Insurance As Well As Medicare “Part D” Drug Plans.

In what seems like a conflict of interest, the top three PBMs are companies that also offer insurance and other healthcare services, including their own pharmacies that compete with independent drug stores. CVS Health owns PBM Caremark and Aetna Insurance, as well as CVS pharmacies, specialty mail-order pharmacies, and a physician’s group. United Health, the insurance giant, owns the mail order pharmacy OptumRx, specialty pharmacies, physician groups and express medical and surgical centers. The insurer Cigna owns the PBM Express Scripts and a specialty pharmacy.

In addition, the reason we could not get UWS pharmacists to speak to us on record about this situation is that there is a “gag clause” in all pharmacy contracts with the PBMs forbidding them to discuss the details of their reimbursements with their patients and customers, under penalty of losing their contracts

So how are our local independent pharmacies staying afloat? Ironically, some generic drugs have a greater profit margin. Additionally “some pharmacies do more [non-prescription] business in the front of the store,” the pharmacist told us. “For some of them, the owner’s working 80 hours a week, and he’s got a skeleton crew.” And some have shortened their days and business hours.

For many, says NYCPS spokesman Tom Corsillo, the neighborhood pharmacy is a lifeline. “People who use independent pharmacies tend to be the most vulnerable populations, folks who need to understand dosage and rely on the level of counsel independent pharmacies provide.”

There have been bipartisan calls for scrutiny and regulation of PBMs at a national level, including hearings on Capitol Hill. And just this last Friday, the Federal Trade Commission announced new action against the three largest PBMs — Caremark Rx, Express Scripts (ESI), and OptumRx — for engaging in what the FTC calls, in a release “anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower list price products, and shifted the cost of high insulin list prices to vulnerable patients.”

For its part, the Pharmaceutical Care Management Association, the PBM’s trade group, defends its members’ practices. In a statement emailed to WSR, PCMA spokesman Greg Lopes said, “PBMs recognize the vital role pharmacies play in creating access to prescription drugs for patients, especially community pharmacies in rural areas. There are unfortunately many factors for pharmacy closures, but blaming PBMs is not based on the facts,” and added, “It should be noted that in New York [State], between 2014 and 2024, the number of independent pharmacies actually grew from 2,470 to 3,058, a 23.8% increase.” But he could not specify in what part of the state that growth had occurred.

The NYC pharmacists’ survey taken in July says that in the year ahead, “96 percent of the respondents indicated they are very likely to stop carrying additional medications if reimbursement rates are further reduced as projected. Additionally, 96 percent of respondents anticipate having to lay off employees or reduce store hours to cope with these financial challenges.”

As for Friday’s FTC complaint, (which only applies to insulin medications) the FTC says it “seeks to put an end to the Big Three PBMs’ exploitative conduct and marks an important step in fixing a broken system—a fix that could ripple beyond the insulin market and restore healthy competition to drive down drug prices for consumers.”

What can concerned citizens do? Corsillo says “you have to contact your elected officials. Ultimately, they’re going to have to write new laws to rein in PBMs and they need to hear from their constituents that this is something they care about.”

[maleexperience-blog]

5

What's the point? Here it is: I started feeling sick about two days after. You know what came to mind...an HIV infection. Oh, I have a prescription for PrEP. I know the risks. I had not taken my PrEP in well over a week, because I hadn't been having sex. I took two tablets as soon as--we'll call him Big Bro--hit me up. So between the time I took a double dose of PrEP and the time he spermed me (fuck yea), only about an hour had passed. I couldn't tell you if that's enough time for the components of Descovy to deposit into my cells. Maybe. But you know how it goes (or do you?): when you feel desired, when a dude who can validate you gives himself to you, when you are the object of his erection...because let's face it: an erection to a man is more than an out for his sperm. No, his erection is comfort; it's safety; it's freedom to be. In the absence of any three, there is no erection.

So, yes, when you are the object of a man's erections and his affections, and it's the "right dude," the right dude who makes you feel validated, desired, affirmed...yea, so much goes out the window. Trust, I wasn't thinking much if at all about whether Descovy had bathed my rectal cells or even been absorbed beyond my stomach walls at that point. One *might* call this compulsive sexual behavior, one *might* call it sexual addiction, even. It can be either, I suppose, depending on your school of thought, but what it can also be? Is deprivation, of space, of freedom, of connection; and the need to utilize whatever time and space I have in this moment to connect in ways men are deprived. So what does this mean? 1) I should really take my PrEP more often; 2) I placed myself and my body at risk in exchange for a powerful, albeit fleeting, intimacy with the masculine spirit. Perceive that how you will, but take note nonetheless, that the power of the masculine spirit reconnecting with itself, is powerful. This wasn't no mating dance. I don't have female brain in a male body. We weren't making no baby, bro. We are two men, who seek the bond we are denied.

I am not sure if HIV is a reasonable space to go in my head, but is it really irrational? Given what disgust and shame we have inflicted on male-male intimacy? To think that after an encounter with a man, healthy looking or not, to think, somewhere in my mind, at whatever level of consciousness..."could it be HIV??" Looking at my symptoms now and the social / occupational contacts I've had, it seems more reasonable to assume I just have COVID; the new variant seems to have a GI element moreso than previous variants (I do have diarrhea pretty bad, smh...TMI, my bad). I'm taking PEP nonetheless. Fortunately I have access to some Biktarvy; *no*, I'm not advocating PEP as a leading solution to prevent HIV, nor am I touting it as even proven to be effective. *Studies are pending.* Shit, though, it's a tool nonetheless.

As much education as I have and as much as I know about HIV, its spread, its effects, its treatments, its progression from a death sentence 50 years ago to a manageable chronic condition today, the power of an intimate encounter still can shake my sensibilities. And honestly? some part of me is saying, "it's fucking worth it." I said what I said; you can read it again.

[unicornery]

I know we American TV viewers all dislike pharmaceutical ads (for their ubiquity and the way it seems drugs would be cheaper w/o them) but it's impressive how quickly I went from seeing ads for HIV drugs like PreP or Biktarvy basically just on the Logo channel, to having them appear on the major networks, during mainstream programming.

[cosxtheta]

I love looking like a gay threat<3

it’s wild cuz if im not dressed insanely gay im still so paranoid when im walking out on the street alone and i always have this moment where i realise no one bothers me because IM the one who looks like im about to jook and mug someone lmaooooooo

[mollyleonaa]

Biktarvy - Bictegravir-Tenofovir alafenamide-Emtricitabine

[ethena11]

Buy Taffic Tablet Online

Taffic Tablet is a cost-effective generic version of Biktarvy. Taffic Tablet combines three essential drugs to effectively suppress the virus, enhancing patient well-being. Its convenient tablet form ensures easy daily administration, promoting treatment adherence. Trust Taffic Tablet for quality and affordability in HIV management. Explore unbeatable healthcare solutions at Drugssquare Pharmacy. Your go-to online pharmacy for reliable medications, we prioritize your well-being with a vast selection of high-quality generic medications at an affordable price. Reach us today for more medications and detailed information. 

[spidersgeorgsblog]

I hate to be an online beggar but my clinic is now charging for my HIV meds that used to be free. Biktarvy is around $3000 but I still have to pay $150 which I don’t have and if anyone out there can help I would greatly appreciate it. I can provide proof of my diagnosis.

PayPal: javicruz1992@gmail.com

Cashapp: $md0669

Any amount can help since I’m only 8 pills away from needing another refill. This medication keeps me undetectable and safe. If anyone can help pls do.

[frogeyedape]

To put it in plain terms:

There is absolutely treatment available for HIV. In addition to preventative PrEP and PEP, there are *lots* of antiretroviral treatments (ARTs) available to treat HIV, including but not limited to Biktarvy (3 ARTs in 1 daily pill) and Cabenuva (2 ARTs, long acting injectable). HIV is not a death sentence. HIV transmission is preventable. HIV treatment exists & there is national funding to help you get ARTs if you're HIV positive (look up Ryan White).

[keynewssuriname]

Drastische veranderingen in gebruik medicatie Caribisch gebied

De gehele wereld kent veranderingen die plaatsvinden binnen de farmaceutische industrie en bij gebruik, toepassing en ontwikkeling van medicatie is dat zeker ook het geval in het Caribisch gebied. Het gebruik van medicatie in het heel Caribisch gebied verandert op rap tempo volgens Rohan Howell, hoofd van het farmaceutisch bedrijf Stein Cares Caribbean. Hij is deel van de delegatie die is meegereisd voor de dermatologen conferentie die wordt gehouden in de ballroom van Hotel Torarica. De conferentie is vrijdag 3 november afgewerkt. Howell geeft aan dat de bedrijven die medicatie vervaardigen en op de markt brengen de afgelopen jaren veel modernere methodes zijn gaan toepassen en er daarbij stilgestaan moet worden. Howell stelt dat verschillende farmaceutische bedrijven nu ook geneesmiddelen ontwikkelen met minder bijwerkingen. Hij benadrukt dat de wetenschap nu zo ver is dat mensen vrijwel geen last ervaren van hun aandoeningen doordat de middelen nu veel doeltreffender zijn. Vooral bij HIV en aids medicatie. “Je kan nu bijvoorbeeld lang leven met HIV/AIDS. Je kan het hebben en aan andere zaken overlijden maar geen HIV/AIDS. Het is niet langer een doodvonnis zoals toen.” Howell verduidelijkt dat hij zelf gesprekken voert met belanghebbenden in Suriname om betaalbare moderne medicatie voor bepaalde chronische ziekten ook in Suriname te krijgen. Hij stelt dat ook in de ontwikkelingslanden mensen moeten kunnen genieten van topzorg en vind het goed als overheden hierop inspelen. De Stein Cares topman zegt dat het middel Bictegravir dat wordt verkocht onder de naam Biktarvy bijvoorbeeld 1 tablet per dag vereist ten aanzien van inname. Dit in vergelijking met de bijna 30 pillen die vroeger ingenomen moesten worden als remmers. Hij geeft aan dat dit een van de voorbeelden is van een bijzondere verandering in de behandeling met ‘zware medicatie’ voor chronische aandoeningen. Dit is dus een puur voorbeeld van de veranderingen op farmaceutisch vlak die teweeggebracht is geworden op de wereld door de ontwikkelingen die niet stil blijven liggen. Read the full article

[biktarvycost]

🌟 Unlocking Affordability: Navigating Biktarvy Costs 🌟

Living with HIV comes with unique challenges, and access to life-saving medications should never be one of them. Let's dive into the world of Biktarvy and explore how you can optimize costs while prioritizing your health.

💊 Understanding Biktarvy: Biktarvy is a groundbreaking medication for managing HIV. Its effectiveness is well-established, but the cost can be a concern for many. Don't worry; you're not alone in this journey.

💡 Exploring Affordability: Affordable options exist. Insurance coverage, patient assistance programs, and different sources can help lower the cost. It's essential to do your research and explore all avenues.

🌎 Global Insights: Did you know that Biktarvy can be significantly more affordable in some countries? It's an eye-opener into how healthcare pricing can vary worldwide.

🤝 Community Support: Joining support groups and engaging with advocates can provide invaluable insights. Sharing experiences and tips on managing costs can be empowering.

🧘 Prioritizing Your Health: Remember, your health should always come first. Work closely with your healthcare provider to find the best treatment plan that aligns with your financial situation.

🚀 Take Charge: You have the power to optimize Biktarvy costs and lead a fulfilling life with HIV. Stay informed, stay empowered!

If you need help to get the price down of Biktarvy, we can help with manufacturer's coupon, patient assistance programs, prescription assistance programs, Biktarvy generic and other options.

You can always email us at help@soulofhealing.org or call us 24/7 at 858-952-1077.

#BiktarvyCost #Biktarvy #BiktarvyMedication #HIVTreatment #AffordableHealthcare #Empowerment #HealthOptimization #YouAreNotAlone

[vhscassette]

as someone who works in HIV+/AIDS+ stuff for my state, just wanted to remind ppl that this med ISNT A VACCINE and IS NOT A CURE, but it is A treatment. which is great! but atm the most universally used one that drs prescribe in the usa atm is biktarvy (which isnt this one) and there are literally dozens of meds for the viral suppression of HIV/AIDS. each has a pro and con and what works for one person may not work for another, etc. but this is still great!!! field of hiv meds is complicated and diverse from country to country, and this is a very small tidbit of info. but hiv med accessibility is wonderful and i highly implore anyone and everyone to get on prep/pop, hoping this med becomes more affordable somehow despite corporate greed!

Source

[cmipooja]

Global Integrase Inhibitors Market Is Estimated To Witness High Growth Owing To Escalating HIV/AIDS Prevalence

The global Integrase Inhibitors Market is estimated to be valued at US$ 29.34 billion in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period of 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Integrase inhibitors are a class of antiretroviral drugs used for the treatment of HIV/AIDS. They work by blocking the action of the integrase enzyme, which is responsible for inserting the viral genetic material into the DNA of the host cell. This prevents the replication of the virus and helps in controlling the progression of HIV infection. The need for effective anti-HIV drugs has become crucial due to the rising prevalence of HIV/AIDS worldwide. According to the World Health Organization (WHO), approximately 38 million people were living with HIV/AIDS in 2019. This high prevalence has led to increased demand for integrase inhibitors, as they offer several advantages over other antiretroviral drugs, such as improved efficacy, better tolerability, lower toxicity, and ease of administration. Market Key Trends: One key trend driving the growth of the global integrase inhibitors market is the development of novel and more potent drugs. Pharmaceutical companies are constantly investing in research and development activities to discover and develop new integrase inhibitors with improved therapeutic outcomes. For instance, Gilead Sciences recently received approval from the U.S. Food and Drug Administration (FDA) for a new integrase inhibitor called Biktarvy. This drug is a combination of three active ingredients and offers high efficacy with a low risk of drug resistance. PEST Analysis: Political: The political environment plays a crucial role in shaping the regulations and policies related to HIV/AIDS prevention and treatment. Governments across the globe are increasingly focusing on combating the HIV/AIDS epidemic by implementing awareness campaigns, providing access to affordable healthcare services, and ensuring the availability of antiretroviral drugs, including integrase inhibitors. Economic: The economic factors influencing the integrase inhibitors market include healthcare expenditure, affordability, and reimbursement policies. The high cost of integrase inhibitors can pose a challenge in low-income countries, where access to these drugs is limited due to financial constraints. However, government initiatives and collaborations with pharmaceutical companies are aimed at reducing the cost of these drugs and making them more accessible to all. Social: Social factors such as awareness, stigma, and healthcare infrastructure influence the adoption of integrase inhibitors. Increasing awareness about HIV/AIDS and the importance of early diagnosis and treatment is driving the demand for integrase inhibitors. Efforts are being made to reduce the stigma associated with HIV/AIDS, which can affect patients' willingness to seek treatment and adhere to medication regimens. Technological: Technological advancements in drug delivery systems and diagnostics have improved the efficacy and accessibility of integrase inhibitors. The development of long-acting formulations and point-of-care testing methods has facilitated better disease management and monitoring. Furthermore, advancements in genetic engineering techniques have enabled the discovery and development of more potent integrase inhibitors. Key Takeaways: - The Global Integrase Inhibitors Market Size is expected to witness high growth, exhibiting a CAGR of 3.9% over the forecast period. This growth can be attributed to increasing HIV/AIDS prevalence globally and the demand for effective antiretroviral drugs. - Regionally, North America is expected to dominate the market due to a well-established healthcare infrastructure, high healthcare expenditure, and favorable reimbursement policies.